June 5, 2024 - June 7, 2024

Magenta Lifecare IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Magenta Lifecare IPO.

Magenta Lifecare IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	1	0	0	0
%	0.00	100.00	0.00	0.00	0.00

Magenta Lifecare IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	May Apply

Magenta Lifecare IPO Review by Dilip Davda (May apply)

[Dilip Davda] The company is operating in a highly competitive and fragmented segment. With its asset light model and cost management, the company is confident of maintaining and improving its performance as indicated by last 21 months working. Based on FY24 annualized earnings, the issue appears aggressively priced. Small equity post-IPO indicates longer gestation for migration. Well-informed/cash surplus investors may park funds for the long term rewards. Read detail review...

Magenta Lifecare IPO Peer Comparison

Magenta Lifecare Limited peer comparison with similar listed entities. (As on March 31, 2023)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Magenta Lifecare Limited	0.53	0.53	11.26	65.97	4.71	3.11
Sheela Foam Ltd	20.81	20.81	164.03	44.65	12.69	6.06	Consolidated
Tirupati Foam Ltd	4.31	4.31	66.04	17.85	6.53		Consolidated

Notes:

1. Net Asset Value per Equity Share is calculated as net worth attributable to equity shareholders as at the end of Fiscal period/year divided by the outstanding number of Equity Shares used in calculating basic earnings per share.

2. All the financial information for listed industry peers mentioned above is on a consolidated basis (unless otherwise available only on standalone basis) and is sourced from the annual reports / annual results as available of the respective company for the year ended March 31, 2023 submitted to Stock Exchanges and our Company's financial information mentioned above is for the financial year ended March 31, 2023.

3. P/E Ratio has been computed based on the closing market price of equity shares on BSE on May 17, 2024 divided by the Diluted EPS provided.

4. Return on Net Worth is computed as restated net profit/(loss) after tax attributable to equity holders of our Company divided by restated average Net Worth for Equity Shareholders of our Company

Magenta Lifecare IPO Review by Members

Magenta Lifecare IPO Reviews, analysis and views by popular members. Read Magenta Lifecare Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Magenta Lifecare IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	1	0	0
%	0.00	100.00	0.00	0.00

Member	Review
Dhanvantri	May Apply for Listing Gain at Upper Price Band As most sme ipo listing at par or at discount Apply if you hope that it will list at premium. June 6, 2024 6:58:47 AM

Member

Review

Dhanvantri

May Apply for Listing Gain at Upper Price Band

As most sme ipo listing at par or at discount Apply if you hope that it will list at premium.

June 6, 2024 6:58:47 AM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.